TGEN - Targeted Genetics Corporation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TGEN - Targeted Genetics Corporation

TGEN 8.230

+0.9%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: tktrimbath	12/31/2004 7:22:39 PM
	Read Replies (1) of 557

my end of year synopsis of TGEN Every six months or so I look at my stocks and try a quick explanation of the company and my position. It helps me remember why I hold the stock, reminds me what I want to do with it, and lets me check back for changes. I encourage folks to comment and show me other points of view. TGEN (market cap $0.127B) might be able to tackle arthritis, AIDS, Cystic Fibrosis and have a ton of cash, but they also have difficulties to overcome. The intellectual property picture is not clear enough with their arthritis treatment. The AIDS work is a vaccine that is only just beginning. It is targeted for non-profits first and therefore has a lot longer to go before it gets to revenue. The CF treatment looks good but it is a small market. If TGEN succeeds at any one of these the stock will rise rapidly. I like the management and will HOLD as they work their way through this, but I wouldn't recommend buying until they've gotten closer to crossing a hurdle or two. There is no reason to sell at such low prices besides for tax loses. At this price it doesn't take much to buy. DISCLAIMER : Not a biotech professional. LTBH since early 2000.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next